Abstract

The aim of this study was to evaluate the effect of breast size on dose heterogeneity. Twenty women underwent a planning CT scan of the thorax. A three-dimensional treatment plan was devised for each patient using a standard technique of isocentric medial and lateral wedged tangential fields. Three-dimensional dose distributions were derived using an equivalent path length (EPL) inhomogeneity correction and cumulative dose-volume histogram (DVH) data calculated for the breast. Analysis of the DVHs for each patient reveals that 0.2–23.8% of the breast received an absorbed dose outside the desired 95–105% of that prescribed at the isocentre. The degree of dose heterogeneity was most strongly correlated with breast volume ( r = 0.70, 95% confidence interval (C.I.) 0.37–0.87). There was also a positive correlation for breast dose heterogeneity versus brassière (bra) cup size (Spearman rank correlation ϱ = 0.62), breast area ( r = 0.39, 95% C.I. −0.06–0.71) and chest wall separation ( r = 0.31, 95% C.I. −0.15–0.66). We conclude that breast size is an important determinant of dose heterogeneity within the breast.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call